Prospective Assessment of Quality of Life and Patient-Reported Toxicities Over the First Year After Chimeric Antigen Receptor T-Cell Therapy. - Hoogland AI; Barata A; Li X; Irizarry-Arroyo N; Jain MD; Welniak T; Rodriguez Y; Oswald LB; Gudenkauf LM; Chavez JC; Khimani F; Lazaryan A; et al. (Transplantation and cellular therapy, 2024)